Editor's update: Emily Ashkin is featured in a podcast from The Lasker Foundation. My legs were starting to ache from standing by my research poster …
Category: Biomedical research
“Like a jewel”: Young scientists help solve a common blood disorder’s mystery
Young scientists contributed to research that revealed the structures of enzymes behind the common disorder G6PD deficiency.
Pain relief device uses real-world evidence to gain clearance, expanding options for kids
Tracking a pain-relief device's success in patients who aren't in clinical trials is seen as a promising approach to expanding treatment options for kids.
How long will a healthy older person live? A substance in blood may provide a clue
Blood levels of a brain-derived substance in people in their 90s and 100s accurately predict how much longer they're going to live.
Less is more? Focused genetic testing recommended for breast and ovarian cancers
Ovarian cancer genetic testing is underused and large gene panels lead to uncertain results, particularly for non-white patients, a Stanford Medicine study finds.
Take heed: Turn to the experts to interpret pharmacogenetic tests
In the burgeoning field of pharmacogenetics, adhering to expert-developed guidelines is increasingly important, a Stanford Medicine physician emphasizes.
A cancer treatment that tackles heart disease?
A Stanford-developed anti-cancer therapy currently in clinical trials may also reduce vascular inflammation in heart disease.
Data from twins suggests that gut bacteria are important in food allergies
A Stanford-led study of twins with and without food allergies has uncovered differences in the fecal bacteria of allergic and non-allergic individuals.
Stanford nanoparticle COVID-19 vaccine shows early success in mice
Stanford University researchers have developed a nanoparticle vaccine that has shown in mouse studies to effectively build coronavirus immunities.
Excised tonsils aid study of COVID-19 vaccines, the flu and more
Stanford scientists transformed tonsils into immunology labs in a dish, aiding research to develop vaccines for COVID-19, the flu and other diseases.
Based on genes, nearly everyone is likely to have an atypical response to at least one drug
Stanford Medicine researchers found that, based on genetic makeup, 99.5% of people are likely to have an atypical response to at least one drug.
Stanford Medicine magazine’s top reads of 2020
Stanford Medicine magazine's most-read articles of 2020 were about COVID-19, grieving and chemo brain, a misunderstood side effect of chemotherapy.
How do the new COVID-19 vaccines work?
The Pfizer and Moderna COVID-19 vaccines are the first to use the RNA coding molecule to prompt our bodies to fight the virus. Here's how they work.
Mapping how the brain thinks, neuron by neuron
Stanford researchers have created a molecular probe designed to map how the brain works by tagging, recording and controlling functions of individual cells.
How one Stanford physician decided to get the COVID-19 vaccine
Stanford Health Care physician Megan Mahoney, MD, describes how conversations with family helped her decide to be among the first to get the COVID-19 vaccine.
Running clinical trials in a pandemic
Doctors and researchers are prioritizing a digital-first approach as they adapt clinical trials to the COVID-19 pandemic.